Stockscreener 앱 받기
3.40
0.58%
-0.02
전일 마감가:
$3.42
열려 있는:
$3.45
하루 거래량:
118.95K
Relative Volume:
0.81
시가총액:
$174.64M
수익:
$63.69M
순이익/손실:
$-44.82M
주가수익비율:
-1.70
EPS:
-2
순현금흐름:
$-30.56M
1주 성능:
-3.68%
1개월 성능:
-5.82%
6개월 성능:
+23.64%
1년 성능:
+84.78%
1일 변동 폭
$3.40
$3.56
1주일 범위
$3.40
$3.80
52주 변동 폭
$1.35
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
Compare MDXH vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
3.40 | 175.67M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-17 | 개시 | Craig Hallum | Buy |
| 2024-10-31 | 개시 | Lake Street | Buy |
| 2023-05-31 | 개시 | TD Cowen | Outperform |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
Mdxhealth Sa 주식(MDXH)의 최신 뉴스
MDxHealth to Release Q4 and Full Year 2025 Financial Results on February 26, 2026, Followed by Conference Call - Quiver Quantitative
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 - The Manila Times
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 - GlobeNewswire Inc.
Bond Watch: Whats the RSI of MDxHealth SA stock2025 Top Gainers & Expert-Curated Trade Recommendations - baoquankhu1.vn
Can MDxHealth SA stock continue upward trendWeekly Loss Report & Stock Portfolio Risk Management - mfd.ru
MDxHealth Details Exosome Diagnostics Deal and Restructured GPS Earnout Obligations - TipRanks
Will MDxHealth SA stock benefit from infrastructure spendingGold Moves & Low Risk Growth Stock Ideas - mfd.ru
Trading Action: Should I invest in MDxHealth SA before earningsJuly 2025 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Aug Shorts: Can Xcel Energy Inc disrupt its industryTrend Reversal & Real-Time Stock Entry Alerts - baoquankhu1.vn
Trend Recap: Whats the RSI of MDxHealth SA stockGlobal Markets & Verified Momentum Stock Watchlist - baoquankhu1.vn
MDxHealth SA (NASDAQ:MDXH) Short Interest Update - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Midday Stock Roundup: MDxHealth Up 9% Since Preliminary Q4, FY Results - Orange County Business Journal
Analysts Expect Breakeven For MDxHealth SA (NASDAQ:MDXH) Before Long - Sahm
MDxHealth SA (NASDAQ:MDXH) Sees Significant Increase in Short Interest - MarketBeat
Retail Surge: How interest rate cuts could boost MDxHealth SA stockSwing Trade & Community Trade Idea Sharing Platform - Bộ Nội Vụ
MDxHealth Posts Preliminary 2025 Results, Expects Revenue Growth Of 26% To 28% In 2026 - Nasdaq
MDxHealth reports 23% revenue growth in Q4, issues 2026 guidance By Investing.com - Investing.com India
MDxHealth Sees Over 20% Revenue Growth in Q4, Full Year - Orange County Business Journal
MDxHealth reports 23% revenue growth in Q4, issues 2026 guidance - Investing.com
MDXH Projects Strong Revenue Growth and Ambitious 2026 Targets - GuruFocus
MDxHealth sees Q4 revenue $30.5M, consensus $26.18M - TipRanks
MDxHealth Posts Strong 2025 Revenue Growth, Sets 2026 Outlook and Revises Exact Sciences Earnout - TipRanks
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences - The Manila Times
Redlands Daily Facts - FinancialContent
MDxHealth (NASDAQ:MDXH) and Biotricity (OTCMKTS:BTCY) Critical Survey - Defense World
How MDxHealth SA stock reacts to job market data2025 Geopolitical Influence & Technical Entry and Exit Tips - ulpravda.ru
Will MDxHealth SA stock attract ESG investors2025 Big Picture & Proven Capital Preservation Methods - ulpravda.ru
Analyst Downgrade: How MDxHealth SA stock reacts to inflationary pressures2025 Pullback Review & High Yield Equity Trading Tips - Улправда
Is MDxHealth SA stock dividend yield sustainableWeekly Market Report & Consistent Income Trade Ideas - Улправда
How MDxHealth SA stock reacts to inflationary pressuresTrade Analysis Summary & AI Forecast for Swing Trade Picks - Улправда
Can MDxHealth SA stock resist sector downturnsJuly 2025 Fed Impact & Capital Protection Trade Alerts - Улправда
MDxHealth announces next phase of collab with University of Oxford - MSN
Loss-Making MDxHealth SA (NASDAQ:MDXH) Expected To Breakeven In The Medium-Term - Yahoo Finance
MDxHealth SAOrdinary Shares (NQ: MDXH - FinancialContent
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer - The Manila Times
World’s largest prostate cancer trial adds genomic test to guide care - Stock Titan
MDxHealth SA (NASDAQ:MDXH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
MDxHealth Files to Sell Up to $200 Million in Shares - marketscreener.com
MDxHealth SA to offer securities up to $200 millionSEC filing - marketscreener.com
Setup Watch: Will MDxHealth SA stock continue dividend increasesWeekly Trend Recap & Expert Verified Movement Alerts - Bộ Nội Vụ
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), MDxHealth (MDXH) and RxSight (RXST) - The Globe and Mail
MDXH: BTIG Reiterates Buy Rating with $7 Price Target | MDXH Sto - GuruFocus
BTIG reiterates Buy rating on MDxHealth stock, maintains $7 price target By Investing.com - Investing.com South Africa
BTIG Research Reaffirms "Buy" Rating for MDxHealth (NASDAQ:MDXH) - MarketBeat
BTIG reiterates Buy rating on MDxHealth stock, maintains $7 price target - Investing.com Australia
How MDxHealth SA stock benefits from tech adoptionMarket Sentiment Review & Capital Efficient Trading Techniques - Улправда
Why MDxHealth SA stock remains undervalued2025 Valuation Update & Weekly Watchlist for Consistent Profits - Улправда
Mdxhealth Sa (MDXH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
1.13%
자본화:
|
볼륨(24시간):